Exposure to Bacillus anthracis Capsule Results in Suppression of Human Monocyte-Derived Dendritic Cells
- 1 August 2014
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 82 (8) , 3405-3416
Abstract
The antiphagocytic capsule ofBacillus anthracisis a major virulence factor. We hypothesized that it may also mediate virulence through inhibition of the host's immune responses. During an infection, the capsule exists attached to the bacterial surface but also free in the host tissues. We sought to examine the impact of free capsule by assessing its effects on human monocytes and immature dendritic cells (iDCs). Human monocytes were differentiated into iDCs by interleukin-4 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF) over 7 days in the presence of capsule derived from wild-type encapsulatedB. anthracisAmes (WT) or a control preparation from an isogenicB. anthracisAmes strain that produces only 2% of the capsule of the WT (capAmutant). WT capsule consistently induced release of IL-8 and IL-6 while thecapAmutant control preparation elicited either no response or only a minimal release of IL-8. iDCs that were differentiated in the presence of WT capsule had increased side scatter (SSC), a measure of cellular complexity, when assessed by flow cytometry. iDCs differentiated in the presence of WT capsule also matured less well in response to subsequentB. anthracispeptidoglycan (Ba PGN) exposure, with reduced upregulation of the chemokine receptor CCR7, reduced CCR7-dependent chemotaxis, and reduced release of certain cytokines. Exposure of naive differentiated control iDCs to WT capsule did not alter cell surface marker expression but did elicit IL-8. These results indicate that free capsule may contribute to the pathogenesis of anthrax by suppressing the responses of immune cells and interfering with the maturation of iDCs.Keywords
This publication has 49 references indexed in Scilit:
- Antibacterial Role for Natural Killer Cells in Host Defense to Bacillus anthracisInfection and Immunity, 2012
- Recent advances in the IL-17 cytokine familyCurrent Opinion in Immunology, 2011
- Inflammatory Cytokine Response to Bacillus anthracis Peptidoglycan Requires Phagocytosis and Lysosomal TraffickingInfection and Immunity, 2010
- Differentiation of Effector CD4 T Cell PopulationsAnnual Review of Immunology, 2010
- Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1β Release from Differentiated THP-1 and Human Monocyte-Derived Dendritic CellsInfection and Immunity, 2010
- Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidinMolecular Microbiology, 2009
- Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogensImmunology, 2009
- Bacillus anthracis Peptidoglycan Stimulates an Inflammatory Response in Monocytes through the p38 Mitogen-Activated Protein Kinase PathwayPLOS ONE, 2008
- Effect of Bacillus anthracis virulence factors on human dendritic cell activationHuman Immunology, 2008
- Poly-γ-Glutamate Capsule-Degrading Enzyme Treatment Enhances Phagocytosis and Killing of EncapsulatedBacillus anthracisAntimicrobial Agents and Chemotherapy, 2007